GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SS Innovations International Inc (OTCPK:SSII) » Definitions » EBIT

SS Innovations International (SS Innovations International) EBIT : $-22.13 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is SS Innovations International EBIT?

SS Innovations International's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-2.62 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-22.13 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. SS Innovations International's annualized ROC % for the quarter that ended in Mar. 2024 was -49.54%. SS Innovations International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -63.99%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. SS Innovations International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -3.19%.


SS Innovations International EBIT Historical Data

The historical data trend for SS Innovations International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SS Innovations International EBIT Chart

SS Innovations International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial -3.37 -1.12 -1.48 -5.44 -20.42

SS Innovations International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.96 -1.76 -1.97 -15.78 -2.62

Competitive Comparison of SS Innovations International's EBIT

For the Medical Devices subindustry, SS Innovations International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SS Innovations International's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SS Innovations International's EV-to-EBIT falls into.



SS Innovations International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SS Innovations International  (OTCPK:SSII) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

SS Innovations International's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-10.872 * ( 1 - 0% )/( (20.515 + 23.379)/ 2 )
=-10.872/21.947
=-49.54 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

SS Innovations International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-10.46/( ( (2.99 + max(13.398, 0)) + (4.189 + max(12.115, 0)) )/ 2 )
=-10.46/( ( 16.388 + 16.304 )/ 2 )
=-10.46/16.346
=-63.99 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.647 + 6.327 + 8.387) - (2.942 + 0.02 + 0.0010000000000012)
=13.398

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.226 + 6.162 + 8.451) - (6.718 + 0.007 + -0.00099999999999945)
=12.115

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

SS Innovations International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-22.127/694.502
=-3.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SS Innovations International EBIT Related Terms

Thank you for viewing the detailed overview of SS Innovations International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


SS Innovations International (SS Innovations International) Business Description

Traded in Other Exchanges
N/A
Address
1500 SE 15th Street, Suite 512, Fort Lauderdale, FL, USA, 33316
SS Innovations International Inc, formerly Avra Medical Robotics Inc develops medical-surgical devices. It invests in four areas including surgical robotic systems, surgical tools, implantable devices, and surgical robotic training. It is a medical robotics company developing a fully autonomous medical robotic system using proprietary software which integrates Artificial Intelligence and Deep Learning, or machine learning. By using an AI and DL-enhanced software program, the company is creating an intelligent robotic system that it believes can robotize a wide range of medical procedures currently being performed by human hands.
Executives
Barry F Cohen director, officer: COO 1600 SOUTHEAST 15TH STREET, APT 512, FORT LAUDERDALE FL 33316
Sudhir Srivastava director, 10 percent owner, officer: Chairman and CEO C/O AVRA SURGICAL ROBOTICS, ONE LIBERTY PLAZA, 35TH FLOOR, NEW YORK NY 10006
Kumar Sethi Anup officer: Chief Financial Officer C-102, DREAM APARTMENTS,, PLOT-14, SECTOR 22, DWARKA, NEW DEHLI K7 110077
Pascual Srivastava Vishwajyoti officer: President 28 HAARBAA, TRIAVENI GARDENS COMPLEX, GADAIPUR MEHRA, NEW DEHLI K7 110030
Sampige Prasannakumar Somashekar director APT 9J, NEST NO 8, 303 LG HALFI, RMV II, BANGALORE K7 560094
Annadurai Mylswamy director #344, NTI LAYOUT, 10TH MAIN, VIDHYARANYAPURA, BANGALORE K7 560067